Shareholders' Equity (Details) - USD ($)	1 Months Ended			12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Mar. 31, 2022	Dec. 31, 2024	Dec. 31, 2023
Stock Repurchase Program [Abstract]
Stock repurchase program, additional amount authorized			$ 2,000,000
Stock repurchase program authorized amount	$ 24,000,000			$ 24,000,000
Stock repurchased during period (in shares)				23,961
Amount paid to repurchase shares during the year				$ 648,152	$ 881,966
Amount of common stock repurchased	$ 20,839,555			$ 20,839,555
Number of common stock acquired (in shares)	1,380,820			1,380,820
Earnings Per Share [Abstract]
Basic weighted average shares outstanding (in shares)				3,165,541	3,176,757
Weighted average dilutive options outstanding (in shares)				0	0
Diluted weighted average shares outstanding (in shares)				3,165,541	3,176,757
Statutory Restrictions [Abstract]
Minimum statutory surplus required to maintain	$ 2,500,000			$ 2,500,000
Period from declaration of ordinary dividend requires notification to insurance commissioner				5 days
Minimum period prior to payment of dividend requires notification to insurance commissioner				10 days
Percentage of statutory capital and surplus	10.00%			10.00%
Ordinary dividends paid				$ 0	$ 2,000,000
Period for which no extraordinary dividends paid				2 years
Outside Directors [Member]
Share-based Compensation [Abstract]
Annual retainer fee paid to director				$ 5,000
Per meeting fee paid to director				$ 2,500
Number of shares issued (in shares)	4,539	4,246
Stock issued during period (in dollars per share)	$ 28.09	$ 30.01		$ 28.09	$ 30.01
Cost of shares issued				$ 127,501	$ 127,422
Management and Employees [Member]
Share-based Compensation [Abstract]
Number of shares issued (in shares)				11,867	26,911
Cost of shares issued				$ 349,312	$ 674,390